1. The effect of foscarnet (phosphonoformate) on human immunodeficiency virus isolation, T-cell subsets, and lymphocyte function;Gaub;AIDS,1987
2. Szoka FC, Jung CC. 1989. Pharmaceutical liposomes containing phosphorous compounds for the treatment of viral infections. WO 8905152.
3. Hostetler KY, Kumar R. 1995. Lipid derivatives of phosphonacids for liposomal incorporation and method of use. US 5463092.
4. Hostetler KY, Mellors JW. 2000. Phosphonoformate lipid analogs for the treatment of drug-resistant human immunodeficiency virus infection. WO 2001047511.
5. Alkoxy propane prodrugs of foscarnet: Effect of alkyl chain length on in vitro antiviral activity in cells infected with HIV-1, HSV-1, and HCMV;Kini;Antiviral Res,1997